Literature DB >> 25917337

Reduction in Inappropriate ICD Therapy in MADIT-RIT Patients Without History of Atrial Tachyarrhythmia.

Valentina Kutyifa1, Arthur J Moss1, Claudio Schuger2, Scott McNitt1, Bronislava Polonsky1, Anne-Christine H Ruwald1, Martin H Ruwald1, James P Daubert3, Wojciech Zareba1.   

Abstract

BACKGROUND: There are limited data whether history of atrial tachyarrhythmia (AT) modifies the risk of inappropriate ICD therapy, or the efficacy of novel ICD programming to reduce inappropriate ICD therapy events.
METHODS: In MADIT-RIT, we investigated the effects of novel ICD programming with high-rate cut-off VT zone ≥ 200 bpm (arm B), or 60-second delayed therapy in the VT zone 170-199 bpm (arm C), compared to conventional programming VT zone>170 bpm (arm A) on first inappropriate ICD therapy in those with or those without AT prior to enrollment.
RESULTS: In patients with prior AT (n = 203, 14%) there was a higher risk of inappropriate ICD therapy (HR = 2.10, 95% CI: 1.38-3.20, P < 0.001), and inappropriate ICD shock (HR = 2.56, 95% CI: 1.38-4.74, P = 0.003) compared to those with no prior AT. The effects of innovative programming to reduce inappropriate ICD therapy with either high-rate cut-off or delayed VT therapy were similar in patients with prior AT (arm B vs. A HR = 0.11, P < 0.001, arm C vs. A HR = 0.17, P < 0.001), and also in patients without prior AT before enrollment (arm B vs. A HR = 0.15, P < 0.001, arm C vs. A HR = 0.24, P < 0.001, interaction P-values >0.10 for all).
CONCLUSIONS: Novel ICD programming with a high-rate cut-off or delayed therapy is equally beneficial to reduce inappropriate ICD therapy in patients with or without prior AT, despite the lower risk of inappropriate ICD therapy in patients without prior AT.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  ICD programming; MADIT-RIT; atrial tachyarrhythmia; inappropriate ICD therapy; outcome

Mesh:

Year:  2015        PMID: 25917337     DOI: 10.1111/jce.12692

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  5 in total

1.  ICD shocks in LVAD patients are not associated with increased subsequent mortality risk.

Authors:  Aswini Kumar; Varun Tandon; David M O'Sullivan; Edmond Cronin; Jason Gluck; Jeffrey Kluger
Journal:  J Interv Card Electrophysiol       Date:  2019-09-10       Impact factor: 1.900

Review 2.  Predictors of mortality and ICD shock therapy in primary prophylactic ICD patients-A systematic review and meta-analysis.

Authors:  Leonard Bergau; Tobias Tichelbäcker; Barbora Kessel; Lars Lüthje; Thomas H Fischer; Tim Friede; Markus Zabel
Journal:  PLoS One       Date:  2017-10-17       Impact factor: 3.240

3.  Atrial Fibrillation Is Associated With Higher Overall Mortality in Patients With Implantable Cardioverter-Defibrillator: A Systematic Review and Meta-Analysis.

Authors:  Usman Mustafa; Parinita Dherange; Rohit Reddy; Joseph DeVillier; Jessica Chong; Alarozia Ihsan; Ryan Jones; Narendra Duddyala; Pratap Reddy; Paari Dominic
Journal:  J Am Heart Assoc       Date:  2018-11-20       Impact factor: 5.501

4.  Risk factors for the first and second inappropriate implantable cardioverter-defibrillator therapy.

Authors:  Nobuhiro Nishii; Takashi Noda; Takashi Nitta; Yoshifusa Aizawa; Tohru Ohe; Takashi Kurita
Journal:  Int J Cardiol Heart Vasc       Date:  2021-04-26

Review 5.  Research Opportunities in Autonomic Neural Mechanisms of Cardiopulmonary Regulation: A Report From the National Heart, Lung, and Blood Institute and the National Institutes of Health Office of the Director Workshop.

Authors:  Reena Mehra; Olga A Tjurmina; Olujimi A Ajijola; Rishi Arora; Donald C Bolser; Mark W Chapleau; Peng-Sheng Chen; Colleen E Clancy; Brian P Delisle; Michael R Gold; Jeffrey J Goldberger; David S Goldstein; Beth A Habecker; M Louis Handoko; Robert Harvey; James P Hummel; Thomas Hund; Christian Meyer; Susan Redline; Crystal M Ripplinger; Marc A Simon; Virend K Somers; Stavros Stavrakis; Thomas Taylor-Clark; Bradley Joel Undem; Richard L Verrier; Irving H Zucker; George Sopko; Kalyanam Shivkumar
Journal:  JACC Basic Transl Sci       Date:  2022-01-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.